Past Events

Dr. Lisa Finkelstein, technology transfer manager at the NCI Technology Transfer Center, discusses the technology transfer agreement process.

Dr. Shahinaz Gadalla, Earl Stadtman Investigator, presents on her research.

Gretchen Gierach presents her research on integrative epidemiological studies of breast cancer - opportunities and implications.

Dr. Zhaoyu Li, Assistant Professor in the Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, discusses Functional Genomics and Quantitative Epigenomics in Cancer Research.

DCEG Seminar: Dr. Mohsen Naghavi presents an overview of the global disease burden project, with a focus on U.S. cancer burden across different states.

List of presentations given by DCEG staff at the virtual 2020 American Association for Cancer Research (AACR) Annual Meeting.

Inaugural Meeting of the International Society for Radiation Epidemiology and Dosimetry will take place May 5-8, 2020, in Sitges, Spain. Investigators in the Radiation Epidemiology Branch

This seminar is Part 3 of 3 of the 2020 Biostatistics at the Frontier seminar series

In this talk, I will present a statistical narrative of two seemingly different but equally exciting topics: Bayes regularization and microbiome multi-omics, drawing upon my PhD and postdoc experience of researching in two vastly different academic settings.

My research interest focuses on the development of statistical methods for analyzing electronic health record data, using these methods to model the natural history of intervening stages in the carcinogenic process, and the development of evidence-based cancer screening guidelines. I will discuss some of the critical statistical challenges involved in analyzing such data, and why standard tools for absolute and relative risk estimation are biased. I will introduce new statistical models that can be used to produce unbiased estimates in cohort studies with multiple time point data and biospecimen collection. These models are used to develop new risk-based management guidelines for cervical cancer. I will also discuss risk models and benefit models for oral cancer and lung cancer screening.